comparemela.com

Latest Breaking News On - Quanex building products corp - Page 9 : comparemela.com

Quanex Building Products (NYSE:NX) Lifted to Buy at StockNews com

Quanex Building Products (NYSE:NX – Get Rating) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Separately, Benchmark reissued a “buy” rating and issued a $28.00 price target on shares of Quanex Building Products in a report on Tuesday, March 14th. Quanex Building Products […]

Quanex Building Products (NYSE:NX) Announces Quarterly Earnings Results, Beats Estimates By $0 25 EPS

Quanex Building Products (NYSE:NX – Get Rating) released its quarterly earnings data on Friday. The construction company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.25, Zacks reports. The business had revenue of $273.54 million during the quarter. Quanex Building Products had a return on equity of 18.33% […]

Advanced Info Service Public (OTCMKTS:AVIFY) Trading Down 3%

Quanex Building Products (NYSE:NX – Get Rating) announced its quarterly earnings results on Friday. The construction company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.25, Zacks reports. Quanex Building Products had a return on equity of 18.33% and a net margin of 6.50%. The business had […]

North American Morning Briefing : Attention Turns -2-

The newest vaccine, from Pfizer for a deadly respiratory virus known by the acronym RSV, was approved in the U.S. on Wednesday. Its green light follows clearance of the first RSV shot from GSK earlier this month and a pneumonia shot from Merck & Co. | 06:12am

North American Morning Briefing: Attention Turns -2-

North American Morning Briefing: Attention Turns -2-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.